CutisPharma Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:$20M
Industry:Pharma
Founded:2000
Lead Investor(s):Ampersand Capital Partners, Silicon Valley Bank
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • CutisPharma's estimated annual revenue is currently $17.3M per year.
  • CutisPharma received $Undisclosed in venture funding in January 2015.
  • CutisPharma's estimated revenue per employee is $201,000
  • CutisPharma's total funding is $20M.

Employee Data

  • CutisPharma has 86 Employees.
  • CutisPharma grew their employee count by 30% last year.
  • CutisPharma currently has 16 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ironwood Pharma...
N/A428N/AN/A
Infinity Pharma...
N/A395N/AN/A
Kala Pharmaceut...
$10.7M140-1%N/A
Karyopharm Ther...
$30.3M37050%N/A
Carna Bioscienc...
$4.6M23N/AN/A
Boston Pharmace...
$14.3M7148%N/A
Vita Data Scien...
$8.4M4250%N/A
Veristat
$38M22015%N/A
Radius Health
N/A436N/AN/A
Sunovion Pharma...
$465.5M2316N/AN/A
Missing a competitor? Contribute!?
Submit

CutisPharma, Inc., based in Wilmington, MA, is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 10 million currently compounded prescriptions, by offering FIRST® Unit-of-Use Prescription Compounding Kits. Use of these branded compounding kits will be beneficial to all triad participants, namely physicians, pharmacists, and patients. Three U.S. patents have been issued to the Company with several additional patents pending.

keywords:N/A

86

Number of Employees

$17.3M

Revenue (est)

16

Current Jobs

30%

Employee Growth %

$20M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Indu MuniPresident & CEO
Neal MuniPresident & CEO
Les SwartzSenior Director, Trade & Distribution
Francisco LozanoVice President Of QualityEmail Available
Twinkle PatelManager Contracts and Pricing at Azurity PharmaceuticalEmail Available
Zeus PendonSenior Director, Formulation Development
Paul SpanelDirector, Trade OperationsEmail Available
Anwar KabirDirector Of Quality Control
Stephen MullenDirector, Quality Assurance
Stephen TorraDirector of Information Technology at Azurity Pharmacueticals

CutisPharma News

03/26/2019 - CutisPharma Continues Growth Trajectory with Opening of ...

WOBURN, Mass., March 26, 2019 /PRNewswire/ -- CutisPharma, Inc. announced today the opening of its new corporate headquarters in ...

06/24/2019 - Massachusetts company acquires pharmaceutical business with OP facility

Massachusetts pharmaceutical company CutisPharma Inc. has acquired Silvergate Pharmaceuticals Inc., creating a new, unified company ...

01/15/2019 - CutisPharma Announces New Management Team ...

WILMINGTON, Mass., Jan. 15, 2019 /PRNewswire/ -- CutisPharma, Inc. announced today the appointments of Mike Radice as Chief ...

CutisPharma Funding

DateAmountRoundLead InvestorsReference
2015-01-05$20.0MUndisclosedArticle
2015-01-07$UndisclosedUndisclosedAmpersand Capital PartnersArticle

CutisPharma Executive Hires

DateNameTitleReference
2014-07-16Neal MuniPresidentArticle
2015-05-20Neal MuniCEOArticle
2016-08-02Steven DinhEVP/Chief Scientific OfficerArticle
2017-08-02Robert PalladinoCFOArticle
2019-01-16Mike RadiceChief Commercial OfficerArticle